1st Quarter - Report

MEHLMAN CONSULTING, INC. for AMNEAL

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Monitoring legislative and regulatory efforts related to domestic supply chains of generic drugs.

Contacted: Food & Drug Administration (FDA); SENATE; White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Manufacturing MAN

Monitoring legislative and regulatory efforts related to domestic manufacturing of generic drugs.

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); White House Office; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.